HIV Remission Through Stem Cell Transplants: A Medical Breakthrough
- A 63-year-old man from Norway has achieved long-term remission from HIV, marking the 10th such case documented worldwide.
- The findings were reported on Monday, April 14, 2026, in the journal Nature Microbiology.
- The patient did not initially seek treatment for HIV, but rather for a rare form of blood cancer.
A 63-year-old man from Norway has achieved long-term remission from HIV, marking the 10th such case documented worldwide. The development follows a complex stem cell transplant procedure, a case now identified in medical research as the Oslo patient
.
The findings were reported on Monday, April 14, 2026, in the journal Nature Microbiology. The patient’s condition is being studied by scientists as a potential pathway toward a future cure for the virus.
Treatment for Blood Cancer Leads to HIV Remission
The patient did not initially seek treatment for HIV, but rather for a rare form of blood cancer. To treat this hematological disease, he underwent a bone marrow stem cell transplant.
During the process, doctors at Oslo University Hospital discovered that the donor—the patient’s brother—carried a rare genetic mutation. This specific mutation provides resistance to the human immunodeficiency virus (HIV).
Because of this discovery, the medical team monitored the procedure closely to see if the transplant would also impact the patient’s HIV status. The mutation in the brother’s stem cells removed a specific receptor in the white blood cells that HIV typically uses to infect the immune system, leaving the virus with nowhere to flourish.
Timeline of Remission
Following the transplant, researchers monitored the patient over several years. Active traces of HIV gradually disappeared from his body.
Two years after the procedure, the patient was able to stop taking his antiretroviral medication. There was no viral rebound following the cessation of treatment.
As of April 14, 2026, there has been no sign of the virus returning five years after the transplant. Marius Trøseid, an author of the study, noted that the patient feels like he has won the lottery twice
because he was cured of both a potentially fatal bone marrow disease and HIV.
Scientific Context and the Berlin Patient
This case adds to a small group of individuals who have achieved remission through similar, though rare, circumstances. The first such milestone occurred in 2009 with Timothy Brown, known as the Berlin patient
.
Brown became the first person to be free of the virus after receiving a specific stem cell transplant. While he later died in 2020 from a relapse of his cancer, his case proved that eradicating the virus was possible.
Javier Martínez-Picado, a researcher at IrsiCaixa and co-leader of the international consortium IciStem, highlighted the importance of these cumulative cases.
At first, they said that a cure was impossible, that the Berlin patient was a fluke. But 10 patients later, we know that it is possible to cure [HIV infection], and what we have to see now is how to scale it up
Javier Martínez-Picado
Challenges in Scaling a Cure
Despite these 10 cases of remission, HIV remains incurable for the general population. As of 2024, the World Health Organization reported that nearly 41 million people were living with the virus.
Current widely available drugs are designed to manage the virus by preventing it from replicating, rather than eradicating it. This means the virus typically re-emerges if medication is stopped.
The stem cell transplant method used for the Oslo patient is difficult to scale to the entire HIV-positive population due to the complexity of the procedure and the requirement for a donor with a very rare genetic mutation.
HIV continues to pose a significant challenge to science because it can integrate itself into the genetic material of CD4 lymphocytes, allowing it to hide from the body’s immune system and mutate rapidly.